Proud to be part of 50 years of pharmaceutical progress in Sabah.
Dr. Annie George is a distinguished Malaysian researcher with over two decades of experience in natural product research, particularly focusing on herbal medicine. Since joining Biotropics Malaysia Berhad in 2007, she has led the research and development of plant-based products, managing 12 clinical trials targeting areas such as men's and women's health, diabetes, cognition, weight management, immune function, and liver health.
Research Contributions and Publications
Dr. George
has authored 31 publications, accumulating over 20,000 reads and 657
citations. Her research has been
published in reputable international journals, including BMC Complementary
Medicine and Therapies. Notable studies
include:
Eurycoma
longifolia (Tongkat Ali): Investigated its effects on stress hormones, mood,
and testosterone levels, demonstrating benefits in stress reduction and
hormonal balance.
Persicaria
minor (BioKesum®): Conducted a six-month randomized, placebo-controlled trial
showing improvements in memory and mood among older adults with mild cognitive
impairment.
NU-PREP
Patents and Innovations
Dr. George
is a co-inventor on 11 patents related to natural products. Notably, she contributed to the development
of a standardized extract of Eurycoma longifolia (Physta®), which has
demonstrated immune-enhancing and anti-viral properties. Additionally, her work on Polygonum minus
has led to innovations in memory enhancement supplements.
Recognition and Impact
Under Dr.
George's leadership, Biotropics Malaysia's Nu-Femme® received the Women's
Health Award at the Functional Food For Wellness Summit 2025, highlighting its
excellence in promoting women's health.
Her contributions have significantly advanced the global recognition of
Malaysian herbal products, ensuring they meet international standards for
safety and efficacy.
PHYSTA
Scientific Backing :
Products like PHYSTA
Tongkat Ali, supported by >17 clinical studies, bridge the gap between
traditional practice and modern science. Studies on efficacy (e.g.,
testosterone enhancement, stress reduction) resonate with health-conscious
consumers.
Trust Boost:
Surveys suggest 60–70% of
consumers in markets like Malaysia and Indonesia are more likely to trust
herbal products with clinical data. In the U.S., this figure rises to 40–50%
among supplement users, up from 20–30% without scientific claims.
Southeast Asia
(Malaysia/Indonesia):
Traditional use of Tongkat Ali is deeply rooted. Scientific validation amplifies trust, shifting acceptance from 50% (traditional use alone) to 70–80% when combined with clinical proof.
U.S. Market:
Skepticism toward herbal
products is higher, but clinical studies help penetrate mainstream wellness
circles. Acceptance grows from 30% (anecdotal claims) to 50% with
science-backed branding.
Pharmacist Endorsement:
Pharmacist
recommendations increase credibility. In regions like the EU and U.S., 65–75%
of consumers trust pharmacist-approved supplements, per industry reports.
Nu-Prep
'Monthly Index of Medical
Specialties' - MIMS.
The percentage of
successful public persuasion varies by region:
Southeast Asia:
70–80%
acceptance for science-backed traditional products, driven by cultural affinity
and clinical validation.
U.S./Europe:
40–55% acceptance, rising as younger demographics prioritize "natural + proven" wellness solutions.
KESUM.
Monthly Index of Medical
Specialties. MINS.
https://www.mims.com/malaysia/drug/search?q=Kesum&mtype=brand
Sabah Pharmaceutical
Society AGM 4th May 2025.
Sabah International Convention Centre (SICC).
Priority Nu-Prep & Kesum, clinically proven - Monthly Index of Medical Specialties (MIMS).
https://www.facebook.com/share/1AXBaGFZcv/
